Gilead Sciences, Inc.

232 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.

Start with

and connect to

Gilead Sciences, Inc.: all 70 bills it lobbied on and all 161 lawmakers it gave to or whose bills it lobbied on. Point at anyone to see how they are linked.Includes 20 other records under the same name, such as its political action committee and state lobbying filings.

Every link on this map

The same connections as a table, with the reason each one is here.

Sort by

Connections of Gilead Sciences, Inc.

SB 966: Pharmacy benefits	Bills it lobbied on	Gilead Sciences, Inc. named SB 966, “Pharmacy benefits”, in 3 lobbying reports.	3 reports
AB 2930: Automated decision systems	Bills it lobbied on	Gilead Sciences, Inc. named AB 2930, “Automated decision systems”, in 2 lobbying reports.	2 reports
AB 1843: Communicable diseases: hepatitis C	Bills it lobbied on	Gilead Sciences, Inc. named AB 1843, “Communicable diseases: hepatitis C”, in 2 lobbying reports.	2 reports
SB 790: Dreissenid mussel infestation prevention: grants	Bills it lobbied on	Gilead Sciences, Inc. named SB 790, “Dreissenid mussel infestation prevention: grants”, in 2 lobbying reports.	2 reports
SB 253: Climate Corporate Data Accountability Act	Bills it lobbied on	Gilead Sciences, Inc. named SB 253, “Climate Corporate Data Accountability Act”, in 1 lobbying report.	1 report
SB 159: HIV: preexposure and postexposure prophylaxis	Bills it lobbied on	Gilead Sciences, Inc. named SB 159, “HIV: preexposure and postexposure prophylaxis”, in 1 lobbying report.	1 report
AB 1185: California Library Services, Equity in Opportunity Act	Bills it lobbied on	Gilead Sciences, Inc. named AB 1185, “California Library Services, Equity in Opportunity Act”, in 1 lobbying report.	1 report
SB 41: Pharmacy benefits	Bills it lobbied on	Gilead Sciences, Inc. named SB 41, “Pharmacy benefits”, in 1 lobbying report.	1 report
AB 1570: Health care coverage: diagnostic imaging	Bills it lobbied on	Gilead Sciences, Inc. named AB 1570, “Health care coverage: diagnostic imaging”, in 1 lobbying report.	1 report
AB 52: Income tax credit: sales and use taxes paid: manufacturing equipment: research and development equipment	Bills it lobbied on	Gilead Sciences, Inc. named AB 52, “Income tax credit: sales and use taxes paid: manufacturing equipment: research and development equipment”, in 1 lobbying report.	1 report
SB 1021: Prescription drugs	Bills it lobbied on	Gilead Sciences, Inc. named SB 1021, “Prescription drugs”, in 1 lobbying report.	1 report
SB 895: California Science and Health Research Bond Act	Bills it lobbied on	Gilead Sciences, Inc. named SB 895, “California Science and Health Research Bond Act”, in 1 lobbying report.	1 report
HR 1492: To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program	Bills it lobbied on	Gilead Sciences, Inc. named HR 1492, “To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program”, in 7 lobbying reports.	7 reports
AB 1460: Prescription drug pricing	Bills it lobbied on	Gilead Sciences, Inc. named AB 1460, “Prescription drug pricing”, in 6 lobbying reports.	6 reports
HR 5376: Impacts and Outcomes for Health Career Training Act	Bills it lobbied on	Gilead Sciences, Inc. named HR 5376, “Impacts and Outcomes for Health Career Training Act”, in 5 lobbying reports.	5 reports
AB 2258: Health care coverage: cost sharing	Bills it lobbied on	Gilead Sciences, Inc. named AB 2258, “Health care coverage: cost sharing”, in 4 lobbying reports.	4 reports
S 998: Medical Supply Chain Resiliency Act	Bills it lobbied on	Gilead Sciences, Inc. named S 998, “Medical Supply Chain Resiliency Act”, in 4 lobbying reports.	4 reports
AB 1277: Sherman Food, Drug, and Cosmetic Law	Bills it lobbied on	Gilead Sciences, Inc. named AB 1277, “Sherman Food, Drug, and Cosmetic Law”, in 4 lobbying reports.	4 reports
AB 1130: California Health Care Quality and Affordability Act	Bills it lobbied on	Gilead Sciences, Inc. named AB 1130, “California Health Care Quality and Affordability Act”, in 3 lobbying reports.	3 reports
AB 70: Gene synthesis providers	Bills it lobbied on	Gilead Sciences, Inc. named AB 70, “Gene synthesis providers”, in 3 lobbying reports.	3 reports
AB 158: Tribal gaming: local agencies	Bills it lobbied on	Gilead Sciences, Inc. named AB 158, “Tribal gaming: local agencies”, in 3 lobbying reports.	3 reports
HR 2213: Medical Supply Chain Resiliency Act	Bills it lobbied on	Gilead Sciences, Inc. named HR 2213, “Medical Supply Chain Resiliency Act”, in 3 lobbying reports.	3 reports
SB 1333: Communicable diseases: HIV reporting	Bills it lobbied on	Gilead Sciences, Inc. named SB 1333, “Communicable diseases: HIV reporting”, in 3 lobbying reports.	3 reports
AB 1791: Physicians and surgeons: continuing education	Bills it lobbied on	Gilead Sciences, Inc. named AB 1791, “Physicians and surgeons: continuing education”, in 3 lobbying reports.	3 reports
SB 212: Solid waste: pharmaceutical and sharps waste stewardship	Bills it lobbied on	Gilead Sciences, Inc. named SB 212, “Solid waste: pharmaceutical and sharps waste stewardship”, in 2 lobbying reports.	2 reports
SB 521: Drug manufacturers: value-based arrangement	Bills it lobbied on	Gilead Sciences, Inc. named SB 521, “Drug manufacturers: value-based arrangement”, in 2 lobbying reports.	2 reports
SB 1361: Prescription drugs: cost sharing: pharmacy benefit managers	Bills it lobbied on	Gilead Sciences, Inc. named SB 1361, “Prescription drugs: cost sharing: pharmacy benefit managers”, in 2 lobbying reports.	2 reports
SB 1307: Pharmacy: pedigree	Bills it lobbied on	Gilead Sciences, Inc. named SB 1307, “Pharmacy: pedigree”, in 2 lobbying reports.	2 reports
AB 593: Income taxes: net operating losses: tax credits: research, development, and testing for diseases	Bills it lobbied on	Gilead Sciences, Inc. named AB 593, “Income taxes: net operating losses: tax credits: research, development, and testing for diseases”, in 2 lobbying reports.	2 reports
SB 873: Prescription drugs: cost sharing	Bills it lobbied on	Gilead Sciences, Inc. named SB 873, “Prescription drugs: cost sharing”, in 2 lobbying reports.	2 reports
HR 1: An act to provide for reconciliation pursuant to title II of H. Con. Res. 14	Bills it lobbied on	Gilead Sciences, Inc. named HR 1, “An act to provide for reconciliation pursuant to title II of H. Con. Res. 14”, in 2 lobbying reports.	2 reports
SB 568: Deductibles: chronic disease management	Bills it lobbied on	Gilead Sciences, Inc. named SB 568, “Deductibles: chronic disease management”, in 2 lobbying reports.	2 reports
AB 1776: Cartwright Act: violations	Bills it lobbied on	Gilead Sciences, Inc. named AB 1776, “Cartwright Act: violations”, in 2 lobbying reports.	2 reports
SB 1303: Public health: hepatitis C	Bills it lobbied on	Gilead Sciences, Inc. named SB 1303, “Public health: hepatitis C”, in 2 lobbying reports.	2 reports
AB 789: Health care services	Bills it lobbied on	Gilead Sciences, Inc. named AB 789, “Health care services”, in 2 lobbying reports.	2 reports
SB 939: Prescription drug pricing	Bills it lobbied on	Gilead Sciences, Inc. named SB 939, “Prescription drug pricing”, in 2 lobbying reports.	2 reports
AB 357: Animal test methods: alternatives	Bills it lobbied on	Gilead Sciences, Inc. named AB 357, “Animal test methods: alternatives”, in 2 lobbying reports.	2 reports
AB 1864: Gene synthesis equipment manufacturers and providers	Bills it lobbied on	Gilead Sciences, Inc. named AB 1864, “Gene synthesis equipment manufacturers and providers”, in 2 lobbying reports.	2 reports
SB 1023: Health care coverage: antiretroviral drugs, drug devices, and drug products	Bills it lobbied on	Gilead Sciences, Inc. named SB 1023, “Health care coverage: antiretroviral drugs, drug devices, and drug products”, in 2 lobbying reports.	2 reports
S 839: Safeguarding Honest Speech Act	Bills it lobbied on	Gilead Sciences, Inc. named S 839, “Safeguarding Honest Speech Act”, in 2 lobbying reports.	2 reports
AB 824: Business: preserving access to affordable drugs	Bills it lobbied on	Gilead Sciences, Inc. named AB 824, “Business: preserving access to affordable drugs”, in 2 lobbying reports.	2 reports
SB 786: Prescription drug pricing	Bills it lobbied on	Gilead Sciences, Inc. named SB 786, “Prescription drug pricing”, in 1 lobbying report.	1 report
AB 112: Medi-Cal eligibility	Bills it lobbied on	Gilead Sciences, Inc. named AB 112, “Medi-Cal eligibility”, in 1 lobbying report.	1 report
AB 554: Health care coverage: antiretroviral drugs, drug devices, and drug products	Bills it lobbied on	Gilead Sciences, Inc. named AB 554, “Health care coverage: antiretroviral drugs, drug devices, and drug products”, in 1 lobbying report.	1 report
S 832: EPIC Act of 2025	Bills it lobbied on	Gilead Sciences, Inc. named S 832, “EPIC Act of 2025”, in 1 lobbying report.	1 report
ACR 28: Triple-Negative Breast Cancer Awareness Month	Bills it lobbied on	Gilead Sciences, Inc. named ACR 28, “Triple-Negative Breast Cancer Awareness Month”, in 1 lobbying report.	1 report
AB 265: Prescription drugs: prohibition on price discount	Bills it lobbied on	Gilead Sciences, Inc. named AB 265, “Prescription drugs: prohibition on price discount”, in 1 lobbying report.	1 report
SB 1270: Pharmacy: Electronic Pedigree Task Force	Bills it lobbied on	Gilead Sciences, Inc. named SB 1270, “Pharmacy: Electronic Pedigree Task Force”, in 1 lobbying report.	1 report
AB 1645: Health care coverage: cost sharing	Bills it lobbied on	Gilead Sciences, Inc. named AB 1645, “Health care coverage: cost sharing”, in 1 lobbying report.	1 report
HR 4299: Protecting Patient Access to Cancer and Complex Therapies Act	Bills it lobbied on	Gilead Sciences, Inc. named HR 4299, “Protecting Patient Access to Cancer and Complex Therapies Act”, in 1 lobbying report.	1 report

Showing 50 of 232

In the news

Reporting about the selected subject. Articles are context and do not establish a connection on this map.

Loading coverage…